Literature DB >> 9023641

Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis.

R Edwards1, D Greenwood.   

Abstract

The mechanisms responsible for reduced susceptibility to imipenem (MIC 2-16 mg/L) were investigated in eight strains of Bacteroides fragilis. All the strains produced elevated levels of beta-lactamase. Four B. fragilis strains produced metallo-beta-lactamase capable of marked imipenem hydrolysis, and these enzymes were shown to be responsible for resistance. There was evidence, from testing susceptibility to imipenem in the presence of clavulanic acid, that increased resistance in two strains was associated with susceptibility to beta-lactamases other than metallo-enzymes. With the remaining two strains there was no evidence of enzymic breakdown of imipenem. Neither of these strains showed evidence of decreased permeability to nitrocefin as judged by a method which takes into account the substrate concentration in the periplasmic space. A low molecular weight PBP, that was not seen in fully sensitive strains of B. fragilis, was detected in four strains in which reduced susceptibility to imipenem was not associated with metallo-beta-lactamase activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9023641     DOI: 10.1093/jac/38.6.941

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria.

Authors:  H M Wexler; D Molitoris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase.

Authors:  Jimena Alba; Yoshikazu Ishii; Kenneth Thomson; Ellen Smith Moland; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  In vitro activities of faropenem against 579 strains of anaerobic bacteria.

Authors:  Hannah M Wexler; Denise Molitoris; Shahera St John; Ann Vu; Erik K Read; Sydney M Finegold
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.

Authors:  Stephanie Petrella; Nathalie Ziental-Gelus; Claudine Mayer; Murielle Renard; Vincent Jarlier; Wladimir Sougakoff
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

6.  Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.

Authors:  Hesna Yigit; Anne Marie Queenan; J Kamile Rasheed; James W Biddle; Antonio Domenech-Sanchez; Sebastian Alberti; Karen Bush; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 7.  Bacteroides: the good, the bad, and the nitty-gritty.

Authors:  Hannah M Wexler
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.